col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


35 Results       Page 1

 [1] 
Elsevier: Joint Bone Spine
  original article Date Title Authors   All Authors
1 [GO] 2024―Nov―17 Factors associated with severity and mortality of COVID-19 in French patients with connective tissue diseases and rheumatoid arthritis: a nation-wide, population-based analysis of the French national medico-administrative SNDS database Lou Kawka, Thibaut Fabacher, Erik Sauleau, Fabienne Coury, Laurent Arnaud
2 [GO] 2023―Jul―22 Evolution of musculoskeletal symptoms in Long COVID: have world health systems been prepared to deal with the Long COVID syndrome? Maria Chiara Maccarone, Daniele Coraci, Gianluca Regazzo, Nicola Sarandria, Anna Scanu, Stefano Masiero
3 [GO] 2023―Jul―05 Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort Léa Perrot, Laurent Boyer, René-Marc Flipo, Hubert Marotte, Edouard Pertuiset, Corinne Miceli, et al. (+6)
4 [GO] 2023―Jul―01 Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves Elodie Drumez, Christophe Richez, Louis Bebear, Muriel Herasse, René-Marc Flipo, Hubert Marotte, et al. (+16)
5 [GO] 2022―Nov―21 Chronic Related Group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic disease: a population-based study of more than forty thousand patients Enrico De Lorenzis, Paolo Parente, Gerlando Natalello, Salvatore Soldati, Silvia Laura Bosello, Andrea Barbara, et al. (+12)
6 [GO] 2022―Sep―20 Interaction of TNFi and conventional synthetic DMARD in SARS-COV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis Carla GS Saad, Matheus SR Silva, Percival D Sampaio-Barros, Julio CB Moraes, Cláudia G Schainberg, Celio R Gonçalves, et al. (+10)
7 [GO] 2022―Aug―06 Evaluation of the prevalence of new-onset musculoskeletal symptoms in patients hospitalized for severe SARS-CoV2 infection during the first two COVID waves in France: a descriptive analysis of the clinical data warehouse of 39 hospitals in France Anna Molto, Pierre Pinson, Nathanael Beeker, Christian Roux
8 [GO] 2022―Jun―15 COVID-19 as a source of poor publications Hervé Maisonneuve
9 [GO] 2022―Apr―28 Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: a cohort study and a systematic review with meta-analysis Maxime Auroux, Benjamin Laurent, Baptiste Coste, Emmanuel Massy, Alexandre Mercier, Isabelle Durieu, et al. (+4)
10 [GO] 2021―Dec―23 Polymyalgia rheumatica following COVID-19 vaccination: a case-series of ten patients Sébastien Ottaviani, Pierre-Antoine Juge, Marine Forien, Esther Ebstein, Elisabeth Palazzo, Philippe Dieudé
11 [GO] 2021―Dec―06 "Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases” Clothilde Gros, Alice-Andrée Mariaggi, Jean-François Meritet, Emma André, Margaux Boisson, Alice Combier, et al. (+8)
12 [GO] 2021―Sep―29 SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID19 vaccine shot as a trigger? Comment on :Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150 Simon Cadiou, Aleth Perdriger, Samuel Ardois, Jean-David Albert, Olivia Berthoud, Alain Lescoat, et al. (+2)
13 [GO] 2021―Jul―24 Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases Pascal Richette, Matthieu Allez, Vincent Descamps, Lucas Perray, Simon Pilet, Augustin Latourte, Milka Maravic
14 [GO] 2021―Jun―17 Answer to Cabona et al « Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy» Joint Bone Spine 2021;88:105238 and to Finsterer and Scorza « SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome». Joint Bone Spine 2021;88:105239 Clemence Coll, Muriel Tessier, Christophe Vandendries, Paul Seror
15 [GO] 2021―Jun―15 SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on : “Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021;88:105196 Josef Finsterer, Fulvio A Scorza
16 [GO] 2021―Jun―12 Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy. Comment on : “Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021;88:105196 Corrado Cabona, Federico Zaottini, Federico Pistoia, Stefano Grisanti, Cristina Schenone, Flavio Villani, et al. (+4)
17 [GO] 2021―May―26 Phenotypic switch from non-active primary Sjögren's syndrome to severe systemic Lupus erythematosus after COVID-19 infection in an elderly man Guillaume Roger, Arthur Pavot, Isabelle Bonnet, Sophie Ferlicot, Xavier Mariette
18 [GO] 2021―May―13 Physical activity and quality of life of patients with rheumatoid arthritis at the time of COVID-19 lockdown: results from Carenity, an online patient community Florence E Lévy-Weil, Sandrine Jousse-Joulin, Vincent Tiffreau, Raymond Perez, Valentin Morisseau, Alexis Bombezin--Domino, René-Marc Flipo
19 [GO] 2021―Mar―27 Impact of the COVID-19 pandemic on therapeutic management of rheumatoid arthritis in Brittany (France) Baptiste Quere, Alain Saraux, Thierry Marhadour, Sandrine Jousse-Joulin, Divi Cornec, Camille Houssais, et al. (+5)
20 [GO] 2021―Feb―07 May polyenthesitis follow COVID-19? Jacopo Ciaffi, Luana Mancarella, Elena Borlandelli, Giancarlo Facchini, Riccardo Meliconi, Francesco Ursini
21 [GO] 2021―Feb―05 Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? Ciro Manzo, Alberto Castagna, Giovanni Ruotolo
22 [GO] 2021―Jan―22 COVID-19 epidemiology in rheumatic diseases in Tuscany: a case control study Paolo Francesconi, Fabrizio Cantini, Francesco Profili, Alessandro Mannoni, Benedetta Bellini, Maurizio Benucci
23 [GO] 2020―Nov―02 COVID-19 in French patients with chronic inflammatory rheumatic diseases: clinical features, risk factors and treatment adherence Félicie Costantino, Léa Bahier, Luis Coronel Tarancón, Ariane Leboime, François Vidal, Lamouri Bessalah, et al. (+2)
24 [GO] 2020―Oct―27 Treatment adherence during the COVID-19 pandemic and the impact of confinement on disease activity and emotional status: a survey in 644 rheumatic patients Clementina López-Medina, Lourdes Ladehesa-Pineda, Ignacio Gómez-García, M. Ángeles Puche-Larrubia, J. Miguel Sequí-Sabater, Pedro Armenteros-Ortiz, et al. (+4)
25 [GO] 2020―Oct―27 Can SARS-CoV-2 trigger reactive arthritis? Daniel Wendling, Frank Verhoeven, Mickael Chouk, Clément Prati
26 [GO] 2020―Sep―18 Answer to Vieira et al « Cytokine profile as a prognostic tool in coronavirus disease 2019 ». Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006 Luca Quartuccio, Maurizio Benucci, Salvatore De Vita
27 [GO] 2020―Sep―17 Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191-93 Matheus Vieira, Georgina Maalouf, Milena Hasan, Alexandre Le Joncour, Esma Karkeni, Merwan Idir, et al. (+9)
28 [GO] 2020―Jul―01 CoVid-19 related dactyitis Juan Salvatierra, Daniel Martínez-Peñalver, Lucia Salvatierra-Velasco
29 [GO] 2020―Jun―10 Leptomeningeal involvement in a patient with systemic lupus erythematosus infecting by COVID-19 Fadime Guven, Hayri Ogul, Asli Turgut, Alperen Tezcan, Mecit Kantarci
30 [GO] 2020―May―27 Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020 Christophe Richez, René-Marc Flipo, Francis Berenbaum, Alain Cantagrel, Pascal Claudepierre, Françoise Debiais, et al. (+7)
31 [GO] 2020―May―20 Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy Luca Quartuccio, Francesca Valent, Enrico Pasut, Carlo Tascini, Salvatore De Vita
32 [GO] 2020―Apr―30 How and why rheumatologists are relevant to COVID-19? Renaud Felten, Emmanuel Chatelus, Laurent Arnaud
33 [GO] 2020―Apr―19 Old and new antirheumatic drugs for the treatment of COVID-19 Maurizio Benucci, Arianna Damiani, Maria Infantino, Mariangela Manfredi, Luca Quartuccio
34 [GO] 2020―Apr―19 Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases Christophe Richez, Estibaliz Lazaro, Maël Lemoine, Marie-Elise Truchetet, Thierry Schaeverbeke
35 [GO] 2020―Apr―19 Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome Luca Quartuccio, Luca Semerano, Maurizio Benucci, Marie-Christophe Boissier, Salvatore De Vita
 [1] 

35 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec